Compositions and methods for non-targeted activation of endogenous genes
AssigneeAthersys, Inc.
InventorsJohn J. Harrington, Stephen Rundlett
Life of this patent
Estimating the term…
Loading patent…
AssigneeAthersys, Inc.
InventorsJohn J. Harrington, Stephen Rundlett
Estimating the term…
The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more ampliflable markers located on the integrated vector. In another embodiment, the invention is directed to activation of endogenous genes by non-targeted integration of specialized activation vectors, which are provided by the invention, into the genome of a host cell. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides methods for isolation of nucleic acid molecules (particularly cDNA molecules) encoding a variety of proteins, including transmembrane proteins, and for isolation of cells expressing such transmembrane proteins which maybe heterologous transmembrane proteins. The invention also is directed to isolated genes, gene products, nucleic acid molecules, to compositions comprising such genes, gene products and nucleic acid molecules, and to vectors and host cells comprising such genes and nucleic acid molecules, that may be used in a variety of therapeutic and diagnostic applications. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
A eukaryotic cell in vitro comprising a vector construct comprising a selectable marker and a transcriptional regulatory sequence that is operably linked to an exon comprising a translational start codon, a secretion signal sequence, and an epitope tag sequence, said exon defined at the 3′ end by an unpaired splice donor site, wherein said vector construct does not contain a targeting sequence.
A eukaryotic cell in vitro comprising a vector construct comprising a transcriptional regulatory sequence that is operably linked to an exon comprising a translational start codon, a secretion signal sequence, and an epitope tag sequence, said exon defined at the 3′ end by an unpaired splice donor site, wherein said vector construct does not contain a targeting sequence, and wherein said construct further comprises one or more amplifiable markers.
A eukaryotic cell in vitro comprising a vector construct, said vector construct comprising a transcriptional regulatory sequence that is operably linked to an exon comprising a translational start codon, a secretion signal sequence, and an epitope tag sequence, said exon defined at the 3′ end by an unpaired splice donor site, wherein said vector construct has integrated, by non-homologous recombination, into the genome of said cell, wherein an endogenons gene in said genome is over-expressed in said cell by up-regulation of the gene in said cell by said transcriptional regulatory sequence on said vector construct.
A method for making a eukaryotic cell comprising a vector constructs said method comprising introducing into a eukaryotic cell in vitro a vector construct comprising a selectable marker and a transcriptional regulatory sequence that is operably linked to an exon comprising a translational start codon, a secretion signal sequence, and an epitope tag sequence, said exon defined at the 3′ end by an unpaired splice donor site, wherein said vector construct does not contain a targeting sequence.
A method for producing an expression product of an endogenous cellular gene or portion thereof comprising:
A eukaryotic cell library comprising a collection of tells in vitro transformed with a vector construct comprising a transcriptional regulatory sequence that is operably linked to an exon comprising a translational start codon, a secretion signal sequence, and an epitope tag sequence, said exon defined at the 3′ end by an unpaired splice donor site, wherein said vector construct is integrated into the genomes of said cells by non-homologous recombination.
A method for producing an expression product of an endogenous gene in a cell comprising:
A method of identifying a protein product over-expressed by an endogenous gene, said method comprising:
A method for expressing a gene or portion thereof, comprising:
A method for activating expression from an endogenous gene comprising:
Dependencies are inferred from the claim text.